rs779939785

Variant summary

Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM1BP4_Moderate

The NM_000070.3(CAPN3):​c.749A>G​(p.Lys250Arg) variant causes a missense change. The variant allele was found at a frequency of 0.00000479 in 1,461,878 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 0.0000048 ( 0 hom. )

Consequence

CAPN3
NM_000070.3 missense

Scores

4
15

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:5

Conservation

PhyloP100: 3.64

Publications

1 publications found
Variant links:
Genes affected
CAPN3 (HGNC:1480): (calpain 3) Calpain, a heterodimer consisting of a large and a small subunit, is a major intracellular protease, although its function has not been well established. This gene encodes a muscle-specific member of the calpain large subunit family that specifically binds to titin. Mutations in this gene are associated with limb-girdle muscular dystrophies type 2A. Alternate promoters and alternative splicing result in multiple transcript variants encoding different isoforms and some variants are ubiquitously expressed. [provided by RefSeq, Jul 2008]
CAPN3 Gene-Disease associations (from GenCC):
  • autosomal recessive limb-girdle muscular dystrophy
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • autosomal recessive limb-girdle muscular dystrophy type 2A
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Myriad Women’s Health, Labcorp Genetics (formerly Invitae)
  • muscular dystrophy, limb-girdle, autosomal dominant 4
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • muscular dystrophy, limb-girdle, autosomal dominant
    Inheritance: AD Classification: LIMITED Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 0 ACMG points.

PM1
In a hotspot region, there are 4 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 1 benign, 10 uncertain in NM_000070.3
BP4
Computational evidence support a benign effect (MetaRNN=0.14366186).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CAPN3NM_000070.3 linkc.749A>G p.Lys250Arg missense_variant Exon 5 of 24 ENST00000397163.8 NP_000061.1
CAPN3NM_024344.2 linkc.749A>G p.Lys250Arg missense_variant Exon 5 of 23 NP_077320.1
CAPN3NM_173087.2 linkc.749A>G p.Lys250Arg missense_variant Exon 5 of 21 NP_775110.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CAPN3ENST00000397163.8 linkc.749A>G p.Lys250Arg missense_variant Exon 5 of 24 1 NM_000070.3 ENSP00000380349.3
ENSG00000258461ENST00000495723.1 linkn.*545A>G non_coding_transcript_exon_variant Exon 9 of 26 2 ENSP00000492063.1
ENSG00000258461ENST00000495723.1 linkn.*545A>G 3_prime_UTR_variant Exon 9 of 26 2 ENSP00000492063.1

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD2 exomes
AF:
0.0000119
AC:
3
AN:
251418
AF XY:
0.0000147
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000479
AC:
7
AN:
1461878
Hom.:
0
Cov.:
32
AF XY:
0.00000688
AC XY:
5
AN XY:
727244
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33480
American (AMR)
AF:
0.00
AC:
0
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.0000812
AC:
7
AN:
86258
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53420
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5766
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
1112000
Other (OTH)
AF:
0.00
AC:
0
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1
2
3
4
5
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
32
ExAC
AF:
0.00000824
AC:
1

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Autosomal recessive limb-girdle muscular dystrophy type 2A Uncertain:2
Dec 13, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces lysine, which is basic and polar, with arginine, which is basic and polar, at codon 250 of the CAPN3 protein (p.Lys250Arg). This variant is present in population databases (rs779939785, gnomAD 0.01%). This variant has not been reported in the literature in individuals affected with CAPN3-related conditions. ClinVar contains an entry for this variant (Variation ID: 289752). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is not expected to disrupt CAPN3 protein function with a negative predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

Jul 30, 2024
3billion
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The variant is observed at an extremely low frequency in the gnomAD v4.0.0 dataset (total allele frequency: <0.001%). In silico tool predictions suggest no damaging effect of the variant on gene or gene product [REVEL: 0.40 (<0.4); 3Cnet: 0.14 (<0.15)]. The same nucleotide change resulting in the same amino acid change has been previously reported to be associated with CAPN3- related disorder (PMID: 35169782 / 3billion dataset). The variant is in cis with likely pathogenic NM_000070.3:c.608C>T (NP_000061.1:p.Ala203Val). Therefore, this variant is classified as uncertain significance according to the recommendation of ACMG/AMP guideline. -

not specified Uncertain:1
Jan 27, 2025
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant summary: CAPN3 c.749A>G (p.Lys250Arg) results in a conservative amino acid change located in the calpain-like thiol protease family domain (IPR001300) of the encoded protein sequence. Three of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 1.2e-05 in 251418 control chromosomes. The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. c.749A>G has been reported in the literature in at least one homozygous individual affected with Limb-Girdle Muscular Dystrophy, however this individual was also found to have an additional homozygous variant in CAPN3 (e.g., Ganaraja_2022). Therefore, these report(s) do not provide unequivocal conclusions about association of the variant with Limb-Girdle Muscular Dystrophy, Autosomal Recessive. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publication has been ascertained in the context of this evaluation (PMID: 35169782). ClinVar contains an entry for this variant (Variation ID: 289752). Based on the evidence outlined above, the variant was classified as uncertain significance. -

Inborn genetic diseases Uncertain:1
Jun 18, 2019
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Uncertain:1
Jul 27, 2016
Eurofins Ntd Llc (ga)
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.071
BayesDel_addAF
Benign
-0.095
T
BayesDel_noAF
Benign
-0.17
CADD
Benign
16
DANN
Uncertain
0.99
DEOGEN2
Benign
0.13
T;.;.;T
Eigen
Benign
-0.41
Eigen_PC
Benign
-0.24
FATHMM_MKL
Uncertain
0.92
D
LIST_S2
Benign
0.76
T;T;T;T
M_CAP
Benign
0.030
D
MetaRNN
Benign
0.14
T;T;T;T
MetaSVM
Uncertain
0.082
D
MutationAssessor
Benign
1.1
.;L;L;L
PhyloP100
3.6
PrimateAI
Benign
0.45
T
PROVEAN
Benign
-1.4
N;N;N;N
REVEL
Uncertain
0.40
Sift
Benign
0.48
T;T;T;T
Sift4G
Benign
0.40
T;T;T;T
Polyphen
0.0, 0.0020
.;B;B;B
Vest4
0.14
MutPred
0.40
Loss of methylation at K250 (P = 0.0229);Loss of methylation at K250 (P = 0.0229);Loss of methylation at K250 (P = 0.0229);Loss of methylation at K250 (P = 0.0229);
MVP
0.90
MPC
0.12
ClinPred
0.36
T
GERP RS
3.1
Varity_R
0.34
gMVP
0.55
Mutation Taster
=68/32
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs779939785; hg19: chr15-42681242; API